Ontology highlight
ABSTRACT:
INSTRUMENT(S): LTQ Orbitrap
ORGANISM(S): Homo Sapiens (human) Mus Musculus (mouse)
TISSUE(S): Breast
DISEASE(S): Breast Cancer
SUBMITTER: Meggie Young
LAB HEAD: Charles E. Foulds
PROVIDER: PXD036644 | Pride | 2023-10-24
REPOSITORIES: Pride
Items per page: 5 1 - 5 of 435 |
Gou Xuxu X Kim Beom-Jun BJ Anurag Meenakshi M Lei Jonathan T JT Young Meggie N MN Holt Matthew V MV Fandino Diana D Vollert Craig T CT Singh Purba P Alzubi Mohammad A MA Malovannaya Anna A Dobrolecki Lacey E LE Lewis Michael T MT Li Shunqiang S Foulds Charles E CE Ellis Matthew J MJ
Cancer research 20231001 19
Transcriptionally active ESR1 fusions (ESR1-TAF) are a potent cause of breast cancer endocrine therapy (ET) resistance. ESR1-TAFs are not directly druggable because the C-terminal estrogen/anti-estrogen-binding domain is replaced with translocated in-frame partner gene sequences that confer constitutive transactivation. To discover alternative treatments, a mass spectrometry (MS)-based kinase inhibitor pulldown assay (KIPA) was deployed to identify druggable kinases that are upregulated by diver ...[more]